These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24627207)

  • 1. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
    Varelas PN; Rickert KL; Cusick J; Hacein-Bey L; Sinson G; Torbey M; Spanaki M; Gennarelli TA
    Neurosurgery; 2005 Feb; 56(2):205-13; discussion 205-13. PubMed ID: 15670368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
    Findlay JM; Jacka MJ
    Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
    Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
    Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
    Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
    Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis.
    Shi L; Xu L; Shi L; Brandon D; Chen S; Zhang J
    Curr Drug Targets; 2017; 18(12):1399-1407. PubMed ID: 26343113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage.
    Ramakrishna R; Sekhar LN; Ramanathan D; Temkin N; Hallam D; Ghodke BV; Kim LJ
    Neurosurgery; 2010 Jul; 67(1):110-7; discussion 117. PubMed ID: 20559098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial.
    Kramer AH; Jenne CN; Zygun DA; Roberts DJ; Hill MD; Holodinsky JK; Todd S; Kubes P; Wong JH
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1241-8. PubMed ID: 25853905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
    Hall B; Parker D; Carhuapoma JR
    Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Computed Tomography-Based Scales with and without Consideration of the Presence or Absence of Intraventricular Hemorrhage in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Inagawa T; Shibukawa M; Hidaka T
    World Neurosurg; 2018 Jun; 114():e926-e937. PubMed ID: 29588235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiodensity of intraventricular hemorrhage associated with aneurysmal subarachnoid hemorrhage may be a negative predictor of outcome.
    Nguyen HS; Li L; Patel M; Kurpad S; Mueller W
    J Neurosurg; 2018 Apr; 128(4):1032-1036. PubMed ID: 28474990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular fibrinolysis has no effects on shunt dependency and functional outcome in endovascular-treated aneurysmal SAH.
    Gerner ST; Kuramatsu JB; Abel H; Kloska SP; Lücking H; Eyüpoglu IY; Doerfler A; Schwab S; Huttner HB
    Neurocrit Care; 2014 Dec; 21(3):435-43. PubMed ID: 24566979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports.
    Azmi-Ghadimi H; Heary RF; Farkas JE; Hunt CD
    Neurosurgery; 2002 Feb; 50(2):421-4; discussion 424-5. PubMed ID: 11844282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage Patients With Cast Ventricles.
    Catapano JS; Rumalla K; Karahalios K; Srinivasan VM; Labib MA; Cole TS; Baranoski JF; Rutledge C; Rahmani R; Jadhav AP; Ducruet AF; Albuquerque FC; Zabramski JM; Lawton MT
    Neurosurgery; 2021 Nov; 89(6):973-977. PubMed ID: 34460915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
    Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
    JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Combined External Ventricular Drainage with Intraventricular Fibrinolysis for the Treatment of Intraventricular Haemorrhage with Acute Obstructive Hydrocephalus.
    Luong CQ; Nguyen AD; Nguyen CV; Mai TD; Nguyen TA; Do SN; Dao PV; Pham HTM; Pham DT; Ngo HM; Nguyen QH; Nguyen DT; Tran TH; Le KV; Do NT; Ngo ND; Nguyen VD; Ngo HD; Hoang HB; Vu HV; Vu LT; Ngo BT; Nguyen BX; Khuong DQ; Nguyen DT; Vuong TX; Be TH; Gaberel T; Nguyen LV
    Cerebrovasc Dis Extra; 2019; 9(2):77-89. PubMed ID: 31408859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.